Current status:
Cancelled Post Market
Current status date:
2010-11-25
Product name:
PHL-SODIUM POLYSTYRENE SULFONATE RETENTION ENEMA
DIN:
02261669
Electronic product monograph is not available
Company:
PHARMEL INC
6111, Avenue Royalmount, Suite 100
Montreal
Quebec
Canada
H4P 2T4
Dosage form(s):
Suspension
Route(s) of administration:
Rectal
Number of active ingredient(s):
1
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
V03AE01 POLYSTYRENE SULPHONATE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
SODIUM POLYSTYRENE SULFONATE
|
250 MG / ML
|